These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 3218351)

  • 1. [Neoglycoproteins to characterize endogenous lectins in distinct differentiated malignant mesotheliomas].
    Berghäuser KH; Jundt G; Schulz A; Gabius HJ
    Verh Dtsch Ges Pathol; 1988; 72():309-11. PubMed ID: 3218351
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoglycoproteins with the synthetic complex biantennary nonasaccharide or its alpha 2,3/alpha 2,6-sialylated derivatives: their preparation, assessment of their ligand properties for purified lectins, for tumor cells in vitro, and in tissue sections, and their biodistribution in tumor-bearing mice.
    André S; Unverzagt C; Kojima S; Dong X; Fink C; Kayser K; Gabius HJ
    Bioconjug Chem; 1997; 8(6):845-55. PubMed ID: 9404657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of membranous staining of mesothelioma.
    King JA; Tucker JA
    Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labeled neoglycoproteins and human lectins as diagnostic and potential functional markers in salivary glands of patients with Sjögren's syndrome.
    Steinfeld S; Penaloza A; Decaestecker C; Rommes S; André S; Schüring MP; Danguy A; Appelboom T; Kiss R; Gabius HJ
    J Rheumatol; 2000 Aug; 27(8):1910-6. PubMed ID: 10955332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of osteopontin in epithelioid mesotheliomas and reactive mesothelial proliferations.
    Tigrani DY; Weydert JA
    Am J Clin Pathol; 2007 Apr; 127(4):580-4. PubMed ID: 17369133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of mesothelioma cells is influenced by the expression of proteoglycans.
    Dobra K; Andäng M; Syrokou A; Karamanos NK; Hjerpe A
    Exp Cell Res; 2000 Jul; 258(1):12-22. PubMed ID: 10912783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podoplanin as a marker for mesothelioma.
    Kimura N; Kimura I
    Pathol Int; 2005 Feb; 55(2):83-6. PubMed ID: 15693854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glyco- and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients.
    Kayser K; Böhm G; Blum S; Beyer M; Zink S; André S; Gabius HJ
    J Pathol; 2001 Feb; 193(2):175-80. PubMed ID: 11180163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin.
    Padgett DM; Cathro HP; Wick MR; Mills SE
    Am J Surg Pathol; 2008 Jan; 32(1):123-7. PubMed ID: 18162779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between simian virus 40 and mesothelioma.
    Rivera Z; Strianese O; Bertino P; Yang H; Pass H; Carbone M
    Curr Opin Pulm Med; 2008 Jul; 14(4):316-21. PubMed ID: 18520265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cadherins, catenins and APC in pleural malignant mesothelioma.
    Abutaily AS; Collins JE; Roche WR
    J Pathol; 2003 Nov; 201(3):355-62. PubMed ID: 14595746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant mesothelioma: current status of histopathologic diagnosis and molecular profile.
    Suster S; Moran C
    Expert Rev Mol Diagn; 2005 Sep; 5(5):715-23. PubMed ID: 16149874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface glycoproteins of differentiating neuroblastoma cells analyzed by lectin binding and flow cytometry.
    Notter MF; Leary JF
    Cytometry; 1987 Sep; 8(5):518-25. PubMed ID: 3665675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyproline-rich glycoproteins and lectins in the defense of plants.
    Esquerré-Tugayé MT
    Prog Clin Biol Res; 1983; 138():177-85. PubMed ID: 6675014
    [No Abstract]   [Full Text] [Related]  

  • 16. Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas.
    Ordóñez NG
    Hum Pathol; 2005 Nov; 36(11):1163-7. PubMed ID: 16260268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
    Ordóñez NG
    Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas.
    Saqi A; Yun SS; Yu GH; Alexis D; Taub RN; Powell CA; Borczuk AC
    Diagn Cytopathol; 2005 Aug; 33(2):65-70. PubMed ID: 16007640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo.
    Langerak AW; De Laat PA; Van Der Linden-Van Beurden CA; Delahaye M; Van Der Kwast TH; Hoogsteden HC; Benner R; Versnel MA
    J Pathol; 1996 Feb; 178(2):151-60. PubMed ID: 8683381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Kit is not expressed in malignant mesothelioma.
    Horvai AE; Li L; Xu Z; Kramer MJ; Jablons DM; Treseler PA
    Mod Pathol; 2003 Aug; 16(8):818-22. PubMed ID: 12920227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.